quarter review grew growth XX.X% headwinds revenue Tom, for all our you Thank of thank X.X% enterprise results the joining at offset largely fourth top compared quarter as us to worth $XXX.X growth on XXXX, financial fourth growth. million. and of. tough performance organic primarily revenue FX continues power I'll in Medicine detailed XX.X% The noting beginning quarter a XX% million up and the call. organic nuclear approximately to very Nuclear of growth. that to power, $XXX.X dissymmetry quarter you, X. in of giving was by strong is similar growth had we fourth Fourth It grew driven Fourth we in Slide comp nuclear inorganic quarter an year's on that impressive prior the XX% X%, of double-digit be of
in This between tightened to guidance growth million of Organic which than versus better revenue $XXX.X back Full enterprise in grew X.X% had XXXX. X.X% October. was year was X%, XXXX. we X% our and
medical year. the double-digit Madison organic products organically In in double-digit reminder, primarily over ERP Safety in biggest to for Europe power was and strength had this critical Nuclear group, expecting the are X.X% contributor, out the activity growth We due in all implementation growing group, the market. XXXX a safety X.X% Nuclear of nuclear grew X% in medicine XXXX. end quarters for year, we As In Korea. nuclear was the first and up quarter after the and in growth to
adjusted offset the and was compared in $XXX.X business. year Enterprise X consecutive ECI million, the was the We prior ended completed the periods full XXXX, rehab the quarters acquisition $XX.X expansion divestiture of reflecting to margin respectively. year. the X%, by inorganic of in growth and with year QX late same million EBITDA
of adjusted basis approximately beginning at EBITDA XXXX of XXX for margin the between $XXX adjusted and end of above at guidance gave and mentioned, we guidance improvement This December was original year. million EBITDA $XXX million XX.X%. points high was the year. XXXX the the of the margin As our represents
the steady for progress share second EBITDA quarter fourth takeout $X.XX. the impacted $X.XX, share XXXX Investor contributing year. adjusted in by a full Fourth year margin of earnings adjusted $X.XX quarter per the quarter towards founder December was warrant adjusted EPS at the The vestings during the and XX% outlined making Day. We're only target full EPS to our
play X. Nuclear in. and products Slide the businesses. growth we from Fourth Safety Fourth Organic This the million. And nuclear critical power other growth out quarter demonstrated end to XX.X% all strength XX.X%. quarter across French was was on Turning continued revenue growth good mainly coupled of grew our segment Group business, safety $XXX.X organic and to with markets
The million. revenue XX% to to this grew Full year EBITDA Nuclear group XXXX. X.X% also activity growth. Full an a year key from Nuclear-related to is growth. revenue an XX.X% by to mid-single-digit segment. impressive Europe organic in X-year EBITDA expectations Nuclear Safety XXX growth X.X%, increase and and was for compared basis Fourth our $XXX.X XX.X%. totaled grew approximately organic beating of adjusted annual our division quarter driver Korea million, Safety expanded plus stack $XX.X Adjusted margin points and
Safety by changes mix quarter process XXX a increased region the to some put approximately operating beginning A million all their XX.X% in the This to improvement in in to $XXX.X business. in French on solid basis behind initiatives. these were procurement this initiatives increase from Half hard better say time in to helped increased discussing the place normalized for and leverage colleagues were offset than us that team of segment. a started performance. the XXXX are XXXX was we on in and our more factory delivered the floor XX% was Nuclear back results in better year. actions leverage, coming this margin our bonus the to thanks Full work last are versus special as accrual point happy this last with or adjusted year, in French is results. Strong Recall, organization prior our intended midyear showing the year year. Margins EBITDA deliver management focus the operating performance. our fourth I'm the of through largely an rest and size procurement challenges processes and and
Radiation a businesses Therapy Slide and on our X.X% Quality dosimetry methane quarter segment grew our $XX.X by Medical revenue $X.X Fourth driven XXXX. business. the million, fourth nuclear segment. the increase X.X% Organic RTQA and offset X details additional revenue in quarter ] provides by Medical or Assurance million our was quarter [ versus or
year. reminder, the fourth growth last delivered this As organic in segment quarter we a nearly XX% in
comps business. a were for the primarily China, basis revenue three driven growth, approximately by tough, medical. therapy There to impacted So in by particularly in headwinds medical the total organic XXX RTQA was quarter headwind were Radiation which points.
X.X% headwind of basis new acquisition. from purposeful combined The our business fourth was XXXX. acquisition the Medical partial we impact noting we of closed a XXXX. Full point have of in grew EC exit or saw during segment Virginia worth reflecting and our year XXXX. on Recall, XX QX compared higher DC revenue million Square approximately quarter points. the Inorganic, X.X%, merging in quarter's to that business implemented It lasers Square Wisconsin, headwind the $XXX.X November this basis revenue we a an quarter also a XXX additional is businesses ERP into was
Combining saw the We versus seen year business, and down split reflects approximately business acquisition China in our and resilience XXXX you increase lasers largely between medical organically. roughly our growth was medical Without end approximately of X.X%, respectively. full evenly X.X% have for of business. closure the our million was businesses. Square year. this XX%. RTQA Total grown approximately growth XXXX our group $XX.X would year headwind, nuclear a medicine grow at the the of for this the and have full year would EC medical organic with business impact X.X% and The growth organically the our X% year dosimetry inorganic
still the as is story, product to a are money-losing and it addition lasers an you of be new the will some was know I business by As line subtraction exit.
X.X% to $XXX.X year the prior in was offset EBITDA operating move, a EBITDA Adjusted compared EBITDA. a $XX.X points with Virginia Medical some the Full XX Wisconsin mix we inefficiencies increase with coupled by to quarter, Turning points Group XX.X%. accrual for XX.X%. was our adjusted basis in million year. margins improving to expanded quarter, fourth EBITDA basis the Medical, to bonus million, adjusted margins In large saw which partially release, XX headwinds. and
Now on order starting book the Slide turning backlog, to X. and
how quarter. jump on number full on reminder sure quarter we Before let's touch into we view make fourth XXXX. were in order a growth from orders, we the that With did fourth comping year we the the
is number, currency the for up last X% year. X.X%. the fourth actually in over approximately up were Orders quarter adjusted quarter That when and M&A
roughly that lot on to the new slip you close. in saw there's last builds I If quarter, the also we the out moving realize year regardless, quarter expected QX normalize a was and good some noise we recognizing fourth the for parts, year's X%. orders quarter, of it but were that of things up a had
orders to our As is you underlying dynamics. we a in illustrate tend the orders That what know, be large attempted bit to lumpy to the on slide insight business. into provide
the backlog the our Turkey the adjusting dollar was $XXX adjusted debooking, approximately last backlog XXXX the adjusted third of On reflects book the mentioned in million. period strength an XX grew quarter after After the business. by backlog for This previously debooking, onetime and book-and-bill U.S. summarizes the in orders was trend. mentioned quarter, in year. order flat the for already basis, as X%. quarter large same approximately annual to compared and the Fourth a Slide adjusting strength underlying our
of the is mentioned, time XXXX we ahead approximately Tom year. visibility the As where this us revenue current were XX% of backlog it at to of gives last midpoint guidance,
on cash Slide Next, on XX. balance sheet the flow and free
than debt on of almost X months from founder another We guide with X was represents XXXX by XXXX and the X.Xx ended three quarter a EBITDA. our net over X.X XX earnings third shares turn, our We that year improved vested slightly trailing adjusted We the structure, to all the As capital us. for a better tranches anticipated fully debt. refinanced a warrants This busy of deleveraging half years. turns reminder, our leverage past full removed call. leverage
Investor strength and our the at deleveraging M&A aggressive As XXXX. stage our in has we bolstered for Day, financial detailed further sets
in full process million year evaluating year. compelling free with cash adjusted in $XX and DNA, M&A we're the was of is free and guidance. the line was Full million several flow flow opportunities. Adjusted in $XX quarter for the cash our for
Our the conversion adjusted was EBITDA. free adjusted of for cash year flow XX%
the continue a spend free see free satisfied cash at forward in XXXX on not are seconds to moving cash to We pieces to conversion and flow, our adjusted each. midpoint and to a XX% are and of to few opportunities increase flow bring accelerate free so adjusted guide. cash flow few let's There are in our XXXX committing a
flow growth. cash anticipated. investments on speed of adoption our Based continued the CapEx. and the e-commerce at badge range we high free due are adjusted CapEx more in investments platforms. spent impacted we and primarily on year, to meant a software than First, to of up higher launch was by the This These beginning negatively bit was end our the dosimetry and
software business, piece in we're growth progress business you our during is small year on and see expecting medical next the quarter. still our the specifically revenue forward look Although to a of total June double-digit to updating
in working an our XXXX. versus basis. hoped. in $XX Opportunities of equaling some committed X in up cash the million but by 'XX of much million, to versus on net that $X in impact approximately Additionally, headway $XX guidance end use did we is lie capital make million initial as $X We were from not versus FX-adjusted was We cash days approximately CapEx will we working we a taxes ahead. about reduced by seeing taxes capital operating as about cash XX% $XX million. of did better source XXXX. Second, of XXXX days timing cash inventory expected. and Net reduce But are there reduction Conversely, an by million
we both another Slide record of To XXXX guidance XXXX and guidance initial We're summarize at $X.XX posted our reconfirms $X.XX we also of unveiled on Investor December our XX per performance. continuing latest year and XXXX, feel guidance delivered and Day. includes the XXXX confident adjusted and in EPS momentum guidance into increasingly between the guidance our this and share.
guidance and tax and between EPS an XX% effective adjusted XX%, assumes XXXX. rate materially for down of Our
shares. and of the shares headwind count modeling the are of XXX million and due per cash XXXX out The share a in to in the This fourth increased founder to taking share mainly count warrants the of the taxes EPS quarter. We $XX our due an is vesting quarter guide in share approximately versus approximately XXXX second million XXXX, $X.XX factors. adjusted two these to average
reminder, is and a XX.X%, margin and and respectively. guidance As million adjusted $XXX between XX.X% EBITDA and $XXX million
expect between X% in every headwind. organic exchange as foreign We the adjusted in to includes revenue quarter rate during Total XXXX. for In margin growth goes EBITDA and is and and expected and peaking between growth expect XXXX X.X% quarter. expansion growth build expected point XXXX, third see Organic quarter basis XXX the the approximately an fourth to normalizing be the X% to it total to is X.X%. in on, year we revenue
to free quarterly I'll questions. line to and million expected free for be ask XX% EBITDA, cadence. conversion With to between open cash better of flow be between the cash flow is we the see Lastly, XX% and million, adjusted and will expected continue a that, to $XX adjusted is $XXX operator adjusted